Quinolone-resistant Neisseria gonorrhoeae in Hong Kong

Sexually Transmitted Diseases

Volumn 23, Issue 2, 1996, Pages 103-108

  Kam, Kai Man ^a,b   Wong, Priscilla Wing ^a   Cheung, May May ^a   Ho, N G Kwan Yee ^a   Lo, Kuen Kong ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b Institute of Pathology   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; HONG KONG; NEISSERIA GONORRHOEAE; NONHUMAN; STRAIN DIFFERENCE;

EID: 9244249775     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199603000-00003     Document Type: Article

References (18)

1. Boslego JW, Hicks CB, Greenup R, Wiener HA, Ciak J, Tramont EC. A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis. Sex Transm Dis 1988; 15(4): 186-191.
2. Black JR, Long JM, Zwicki BE, et al. Multicenter randomized study of single-dose ofloxacin vs umoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother 1989; 33:167-170.
3. Clendennen TE, Echeverria P, Saengeur S, Kees ES, Boslego JW, Wignall FS. Antibiotic susceptibility survey of Neisseria gonorrhoeae isolates in Thailand. Antimicrob Agents Chemother 1992; 36:1682-1687.
4. Kumamato Y, Sakai S, Hirose T, et al. Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis. Jpn J Antibiot 1988; 41:1445-1479 (in Japanese).
5. Kam KM, Lo KK, Lai CF, Lee YS, Chan CB. Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong. Antimicrob Agents Chemother 1993; 37:2007-2008.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved Standard. Villanova, PA:NCCLS Document M7-A3 1993; vol. 13, no. 25.
7. Knapp JS, Tam MR, Nowinski RC, Holmes KK, Sandström EG. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984; 150:44-48.
8. Bygdeman SM, Gillenius E-C, Sandstrom EG. Comparison of two different sets of monoclonal antibodies for the serological classification of Neisseria gonorrhoeae. In: Schoolnik GK, Brooks GF, Falkow S, et al (eds). The pathogenic neisseriae. Washington DC: American Society for Microbiology, 1985:31-36.
9. Sandström E, Tam M, Bygdeman S. Antigenic drift of gonococcal protein I as judged by serovar determination. In: Schoolnik GK, Brooks GF, Falkow S, et al (eds). The pathogenic neisseriae. Washington, DC: American Society for Microbiology, 1985:13-19.
10. Danielsson D, Faruki H, Dyer D, Sparling PF. Recombination near the antibiotic resistance locus penB results in antigenic variation of gonococcal outer membrane protein I. Infect Immun 1986; 52(2):529-533.
11. Wolfson JS, Hooper DC, Ng EY, Souza KS, McHugh GL, Swartz MN. Antagonism of wild-type and resistant Excherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers. AntimicrobAgentsChemother1987;31:1861-1863.
12. Yamagishi J-I, Furutani Y, Inoue S, Ohue T, Nakamura S, Shimizu M. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol 1981; 148:450-458.
13. Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 1986; 30:248-253.
14. Hooper DC, Wolfson JS, Ng EY, Swartz MN. Mechanisms of action and resistance to ciprofloxacin. Am J Med 1987; 82(Suppl 4A):12-20.
15. Kam KM, Lo KK, Ho Ng KY, Cheung MM. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin Med 1995; 71:141-144.
16. Tanaka M, Kumazawa J, Matsumoto T, Kobayashi I. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med 1994; 70:90-93.
17. Bogaerts J, Tello WM, Akingeneye J, Mukantabana V, Van Dyck E, Piot P. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoeae and decrease of in-vitro susceptibility to quinolones over time in Rwanda. Genitourin Med 1993; 69:196-200.
18. Barry AL, Jones RN. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations. Antimicrob Agents Chemother 1984; 25:775-777.